Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Archives of Medical Research|April 1, 2008
Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levelsBaris Akinci, Abdurrahman Comlekci, Serkan Yener, et al.Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|June 5, 2009
Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazoneSerkan Yener, Abdurrahman Comlekci, Baris Akinci, et al.Endocrine Journal|November 9, 2006
Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacementBaris Akinci, Abdurrahman Comlekci, Mehmet Ali Ozcan, et al.Indian Journal of Endocrinology and Metabolism|July 2, 2016
Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statementSanjay Kalra, Zafar A Latif, Abdurrahman Comlekci, et al.Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|October 6, 2007
Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidismLevent Kebapcilar, Baris Akinci, Firat Bayraktar, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 29, 2009
Effect of levothyroxine replacement therapy on paraoxonase-1 and carotid intima-media thickness in subclinical hypothyroidismLevent Kebapcilar, Abdurrahman Comlekci, Pinar Tuncel, et al.Endocrine|March 2, 2017
Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolismSerkan Yener, Leyla Demir, Mustafa Demirpence, et al.Journal of Diabetes and Its Complications|May 19, 2015
Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS studyPablo Aschner, Bipin Sethi, Fernando Gomez-Peralta, et al.Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 17, 2010
Effect of levothyroxine suppression therapy on plasma thrombin activatable fibrinolysis inhibitor antigen levels in benign thyroid nodulesBaris Akinci, Tevfik Demir, Abdurrahman Comlekci, et al.Clinical Endocrinology|January 14, 2009
Levothyroxine (LT4) suppression treatment for benign thyroid nodules alters coagulationTevfik Demir, Baris Akinci, Abdurrahman Comlekci, et al.Pageof 5